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Abstract 
The emerging field of synthetic biology—with the potential for engineering 
life from scratch—has inherited the laws and regulations of its biotechnology 
precursor. Yet, synthetic biology allows scientists to do entirely new things. This 
Article considers the resulting legal and ethical issues after surveying the 
technological capabilities developed within the field of synthetic biology. 
I. Introduction 
When Zika swept the world a few years ago, one of the proposed 
solutions was to adapt male Aedes aegypti mosquitoes so that when they 
mated with female mosquitoes in the wild, they would produce offspring that 
could not survive to adulthood, thereby reducing the mosquito population.1 
Although not ultimately adopted, this is only one of several high-profile uses 
of synthetic biology; others include possible cures to many of the worst 
ailments plaguing humanity. Such technology is coming onto the 
marketplace, fueled by billions of dollars of funding for synthetic biology 
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1. Julie Steenhuysen, U.S. One Step Closer to Releasing Engineered Mosquito to Fight Zika, 
REUTERS (Aug. 8, 2016), https://www.scientificamerican.com/article/u-s-one-step-closer-to-
releasing-engineered-mosquito-to-fight-zika/ [https://perma.cc/EQ2L-XJVE]. 
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companies,2 and already has “been used to manipulate information, construct 
materials, process chemicals, produce energy, provide food, and help 
maintain or enhance human health and our environment.”3   
This relatively new field has been described as a cross between biology 
and engineering, which aims to design and construct “new biological parts, 
devices, and systems, and the re-design of existing, natural biological 
systems for useful purposes.”4 If biology raises legal and ethical concerns, 
then so does synthetic biology. This Article considers these concerns after 
surveying the technological capabilities developed within the field of 
synthetic biology.   
II.  The Science  
The blueprint for life in every self-sustaining organism is contained 
within its deoxyribonucleic acid, or DNA. Embedded in the DNA are genes, 
which are essentially the instructions for making specific proteins. These 
proteins, in turn, make up all essential structures, including tissues and organs 
found within an organism. DNA also encodes regulatory elements, which 
ensure that proteins are made in the right place and at the right time. Small 
differences in the genetic material encoding genes are essentially what 
differentiate species, with more closely related organisms sharing a larger 
percentage of their DNA.5 
An essential feature of the genetic material DNA is that it exists in the 
form of a double helix comprising two complementary strands of opposite 
polarity, as first deduced by Watson and Crick based on Franklin’s fiber 
diffraction image of hydrated DNA.6 Natural DNA comprises four nitrogen-
containing bases: A (adenine), T (thymine), G (guanine), and C (cytosine). 
Within the double helix, A pairs exclusively with T and G with C. As noted 
by Watson and Crick, “It has not escaped our notice that the specific pairing 
we have postulated immediately suggests a possible copying mechanism for 
 
2. Calvin Schmidt, These 98 Synthetic Biology Companies Raised $3.8 Billion in 2018, 
SYNBIOBETA (Dec. 19, 2018), https://synbiobeta.com/these-98-synthetic-biology-companies-
raised-3-8-billion-in-2018/ [https://perma.cc/3CF7-7GKV]. 
3. Drew Endy, Foundations for Engineering Biology, 438 NATURE 449, 449 (2005). 
4. Synthetic Biology, NATURE.COM, https://www.nature.com/subjects/synthetic-biology 
[https://perma.cc/64PF-5A5Y]. 
5. For example, chimps share 99% of human DNA, but that 1% difference results in a very 
different species. Kate Wong, Tiny Genetic Differences between Humans and Other Primates 
Pervade the Genome, SCI. AM. (Sept. 1, 2014), https://www.scientificamerican.com/article/tiny-
genetic-differences-between-humans-and-other-primates-pervade-the-genome/ [https://perma.cc/
6M25-48DU]. 
6. Rosalind E. Franklin & R.G. Gosling, Molecular Configuration in Sodium Thymonucleate, 
171 NATURE 740, 740–741 (1953); J.D. Watson & F.H.C. Crick, A Structure for Deoxyribose 
Nucleic Acid, 171 NATURE 737, 737 (1953). 
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the genetic material.”7 During replication, the strands are separated by a DNA 
helicase and copied by a DNA polymerase. Each strand directs synthesis of 
a complementary strand through base pairing; the result is an exact copy of 
the original duplex. 
One of the first advances fueling the field of recombinant DNA 
technology was the development of methods for synthesizing DNA. 
Previously, these bases had to be synthesized from sugar cane or taken from 
living organisms, such as salmon.8  
These bases can then be arranged in any sequence to build variants of 
genes or entirely new genes. In theory, “DNA sequences can be assembled 
together like building blocks, producing a living entity with any desired 
combination of traits.”9 Synthetic biologists can now make DNA sequences 
according to published gene sequence information or obtain them from DNA 
foundries such as the BioBricks Foundation, which offers a catalog of 
standardized genetic sequences that encode proteins that perform specified 
biological functions when inserted into an organism.10 
The ability to synthesize any natural sequence of interest is just the 
beginning. Synthetic biologists have now gone beyond what nature provides 
in the form of nitrogen-containing bases and created entirely new bases with 
the ability to pair, effectively expanding the genetic code from the 4 letters 
found in natural DNA to 6,11 and most recently, 8 letters (A, T, C, G, Z, P, S, 
and B) in hachimoji DNA.12 The latter expanded genetic system—hachimoji 
DNA—retains the exclusive pairing mechanism found in natural DNA. This 
is synthetic biology, which creates new genomes and thus new proteins and, 
ultimately, new life.  
The ability to insert synthetic DNA into cells was the foundation for the 
field of recombinant DNA technology, which is routinely used to express 
proteins of interest in bacteria or other cells and then purified for further 
 
7. Watson & Crick, supra note 6, at 397. 
8. See, e.g., DNA-Na (Salmon Milt Extract), FABRICHEM, https://fabricheminc.com/cosmetic-
oral-care-ingredients/dna-na-salmon-milt-extract/ [https://perma.cc/M5TS-WWQE]. 
9. Gregory N. Mandel & Gary E. Marchant, The Living Regulatory Challenges of Synthetic 
Biology, 100 IOWA L. REV. 155, 159 (2014).   
10. BIOBRICKS FOUNDATION, https://biobricks.org/ [https://perma.cc/6XWJ-4LDK].  
11. See generally Millie M. Georgiadis et al., Structural Basis for a Six Nucleotide Genetic 
Alphabet, 137 J. AM. CHEMICAL SOC’Y 6947 (2015); Kiyofumi Hamashima et al., Creation of 
Unnatural Base Pairs for Genetic Alphabet Expansion Toward Synthetic Xenobiology, 46 CURRENT 
OPINION CHEMICAL BIOLOGY 108 (2014); Yorke Zhang et al., A Semisynthetic Organism 
Engineered for the Stable Expansion of the Genetic Alphabet, 114 PROC. NAT’L ACAD. SCI. 1317 
(2017).  
12. See generally Shuichi Hoshika et al., Hachimoji DNA and RNA: A Genetic System with 
Eight Building Blocks, 363 SCI. 884 (2019).  
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functional characterizations.13 This artificial DNA can be introduced within 
a cell in the form of a plasmid (small circular DNA) that will be replicated 
transiently by the cellular machinery or within the context of an element that 
will integrate into the host’s genome and become a permanent part of that 
organism’s genetic material.14 Extending that technology to the field of 
synthetic biology, the genomics research institute J. Craig Venter Institute 
announced in 2010 in Science that it had created the first synthetic cell,15 
whose synthetic DNA had a watermark to distinguish it from natural DNA to 
prove its synthetic origins. In this case, the cell’s original DNA was gutted 
and replaced by the synthetic DNA.  
Thus far, synthetic biologists have been using simple organisms to 
generate proteins of interest but may in the future create entirely new 
organisms. Even a simple cell is sufficient for certain goals—a cell can 
“produce valuable chemical compounds, assemble beautiful structures, move 
with purpose, and process information.”16 Examples include a protein that 
can strengthen immunity or produce insulin for a diabetic, bacteria and 
viruses that create diesel gas or synthetic fibers, or organisms that perform as 
poison sensors or pollution eaters.17 A recent commercial application 
modified yeast to produce rose oil for perfume instead of extracting it from 
Turkish roses through burdensome procedures.18 
Synthetic biology modifies the behaviors of an organism for essentially 
one of two purposes. The first is to redesign existing biological systems and 
the second is to create entirely new ones that do not already exist in the 
natural world.19  
The origins of the possibilities for synthetic biology started a long time 
ago. With technological breakthroughs in DNA sequencing, it has been 
 
13.  Jeremy Cubert, U.S. Patent Policy and Biotechnology: Growing Pains on the Cutting Edge, 
77 J. PAT. & TRADEMARK OFF. SOC’Y 151, 153–54 (1995); see also Stephen H. Schilling, Note, 
DNA as Patentable Subject Matter and a Narrow Framework for Addressing the Perceived 
Problems Caused by Gene Patents, 61 DUKE L.J. 731, 735 n.32 (2011).   
14. Cubert, supra note 13, at 153–54. 
15. Jordan Paradise & Ethan Fitzpatrick, Synthetic Biology: Does Re-Writing Nature Require 
Re-Writing Regulation?, 117 PENN ST. L. REV. 53, 53 (2012). 
16. Bryan A. Bartley et al., Synthetic Biology: Engineering Living Systems from Biophysical 
Principles, 112 BIOPHYSICAL J. 1050, 1050 (2017). 
17. Brendan Parent, Reproduction-Powered Industry: Coordinating Agency Regulations for 
Synthetic Biology, 15 N.C. J.L. & TECH. 307, 309, 311 (2014). 
18. Justin Chen, A Rose by Any Other Name Would Smell as Yeast, MIT NEWS (July 14, 2017), 
http://news.mit.edu/2017/rose-by-any-other-name-would-smell-as-yeast-emily-havens-greenhagen
-0714 [https://perma.cc/UQ4R-6NCT]; see also Sarah Zhang, A Perfume That Smells Like Roses—
But Is Actually Made from Yeast, GIZMODO (Mar. 5, 2015), https://gizmodo.com/a-perfume-that-
smells-like-roses-but-is-actually-made-f-1689526675 [https://perma.cc/P6ZW-5FS4]. 
19. Jonathan Kahn, Synthetic Hype: A Skeptical View of the Promise of Synthetic Biology, 45 
VAL. U. L. REV. 1343 (2011).  
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possible to sequence entire genomes of organisms from bacteria to humans. 
Through sequencing, researchers found that genome sizes are quite disparate. 
For example, the human genome contains 3.2 billion base pairs while that of 
E. coli has 4.6 million base pairs.20 They also found that the predicted number 
of genes for specific organisms does not correlate well with the size of the 
genome or perceived complexity of that organism. Humans, for example, 
have about the same number of genes, approximately 20,000, as mice and 
nematodes.21  
Researchers then developed tools that could isolate, cut, transfer, and 
insert genes from one organism to another.22 They thus started editing DNA 
sequences.  
Synthetic biologists are now creating novel DNA from scratch. They are 
not just reading and rearranging genetic code, or even substituting DNA in 
one organism for that in another, but writing it.23   
III.  The Law 
Currently, pre-existing regulations governing biotechnology are applied 
to synthetic biology despite the differences between the two fields.24 One 
distinction is that biotechnology uses living organisms or their parts to 
develop or create different products, while synthetic biology can use 
laboratory-created materials to create living organisms.25 Another unique 
characteristic of synthetic biology is that it uses engineering principles to 
intentionally build organisms.26 In other words, “[w]hile traditional 
biotechnology involves the transfer of a small amount of genetic material 
 
20. Carl Zimmer, And the Genomes Keep Shrinking . . . , NATIONAL GEOGRAPHIC: THE LOOM 
(Aug. 23, 2013), https://www.nationalgeographic.com/science/phenomena/2013/08/23/and-the-
genomes-keep-shrinking.html [https://perma.cc/2NLN-QNMN]. 
21. Leslie A. Pray, Eukaryotic Genome Complexity, NATURE EDUCATION (2008), 
https://www.nature.com/scitable/topicpage/eukaryotic-genome-complexity-437/ [https://perma.cc/
Q2SV-YZLH].  
22. Parent, supra note 17, at 311. 
23. FRIENDS OF THE EARTH U.S., INT’L CTR. FOR TECH. ASSESSMENT, & ETC GRP., The 
Principles for the Oversight of Synthetic Biology (Dec. 12, 2012), https://www.etcgroup.org/
sites/www.etcgroup.org/files/The%20Principles%20for%20the%20Oversight%20of%20Synthetic
%20Biology%20FINAL.pdf [https://perma.cc/B975-WHXL]. 
24. Mandel & Marchant, supra note 9, at 173. Cf. Parent, supra note 17, at 310; John D. Loike 
& Robert Pollack, Ethical Boundaries Needed on the Use of Synthetic DNA, THE SCIENTIST (Mar. 
1, 2019), https://www.the-scientist.com/news-opinion/opinion--ethical-boundaries-needed-on-the-
uses-of-synthetic-dna-65549 [https://perma.cc/W326-M4ZD]. 
25. Luis Serrano, Synthetic Biology: Promises and Challenges, 3 MOLECULAR SYS. BIOLOGY 
158, 159 (2007). 
26. Luis Campos, That Was the Synthetic Biology That Was, in SYNTHETIC BIOLOGY: THE 
TECHNOSCIENCE AND ITS SOCIETAL CONSEQUENCES 5, 17 (Markus Schmidt et al. eds., 2009). 
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from one species to another, synthetic biology will permit the purposeful 
assembly of an entire organism.”27  
Nonetheless, biotechnology laws and regulations also apply to synthetic 
biology, thus far having been determined sufficient to govern this area.28 The 
legal framework governing biotechnology—and now synthetic biology—
was established by the Coordinated Framework for Regulation of 
Biotechnology (Coordinated Framework).29 The White House Office of 
Science and Technology Policy proposed this framework in 1984 and 
finalized it in 1986.30  It outlined the U.S. policy for regulating the 
development of products derived from biotechnology.31 The Coordinated 
Framework determined that genetically engineered organisms did not pose 
any unique risks in comparison to those conventionally created.32 Thus, 
genetically engineered products are regulated instead of their processes, and 
contemporary laws were determined sufficient to address the risks.   
In response to the J. Craig Venter Institute’s announcement of its 
creation of the first synthetic cell in 2010, President Obama asked his 
Commission for the Study of Bioethical Issues to examine the risks of 
synthetic biology. The Presidential Commission released its report New 
Directions: The Ethics of Synthetic Biology and Emerging Technologies in 
2010.33 Although it recommended “prudent vigilance” to oversee synthetic 
biology, it provided no specific recommendations for oversight.34   
The Coordinated Framework therefore continues to provide the current 
regulatory oversight. Today, federal agencies continue to regulate the 
product, not the process, of synthetic biology. However, the process itself 
 
27. Mandel & Marchant, supra note 9, at 157. 
28. “Our research concludes that the U.S. regulatory agencies have adequate legal authority to 
address most, but not all, potential environmental, health and safety concerns posed by anticipated 
near-term microbes, plants, and animals engineered using synthetic biology. Such near-term 
products are likely to represent incremental changes rather than a marked departure from previous 
genetically engineered organisms. However, we have identified two key challenges to the current 
U.S. regulatory system posed by the introduction of organisms engineered using synthetic biology 
into the environment.” SARAH R. CARTER ET. AL, J. CRAIG VENTER INSTITUTE, SYNTHETIC 
BIOLOGY AND THE U.S. BIOTECHNOLOGY REGULATORY SYSTEM: CHALLENGES AND OPTIONS 4 
(May 2014), https://www.jcvi.org/sites/default/files/assets/projects/synthetic-biology-and-the-us-
regulatory-system/full-report.pdf [https://perma.cc/H823-ZC3Z]. 
29. Executive Office of the President, Office of Science and Technology Policy, Coordinated 
Framework for Regulation of Biotechnology (June 26, 1986), https://www.aphis.usda.gov/brs
/fedregister/coordinated_framework.pdf [https://perma.cc/TZB2-DNDR]. 
30. Id. at 13. 
31. See generally id. 
32. Parent, supra note 17, at 346–47. 
 33. PRESIDENTIAL COMMISSION FOR THE STUDY OF BIOETHICAL ISSUES, NEW DIRECTIONS: 
THE ETHICS OF SYNTHETIC BIOLOGY AND EMERGING TECHNOLOGIES (2010). 
34. Id. at 27. 
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might have dangers in it, such as fuel-producing algae gone awry.35 
Furthermore, “the conventional regulatory focus on end-products may be a 
poor match for novel organisms that produce products.”36 However, there is 
no doubt that it is also important to regulate the products of synthetic biology, 
which may go on to interact with the natural environment and humans. 
U.S. agencies involved in the regulation of synthetic biology include the 
Environmental Protection Agency (EPA), the Food and Drug Administration 
(FDA), and the Department of Agriculture (USDA).37 Much of the oversight 
of synthetic biology comes from the EPA’s Chemicals Program under the 
authority of the Toxic Substances Control Act (TSCA), which regulates the 
manufacture, use, distribution in commerce, and disposal of “chemical 
substances and mixtures.”38 Through the Coordinated Framework policy 
statement and a 1997 EPA Rule, new microorganisms formed through 
deliberate combinations of genetic material—such as those produced in 
synthetic biology—are included as substances within this authority.39 
Anyone intending to manufacture, import, or process microorganisms for 
commercial purposes is required to file either a Microbial Commercial 
Activity Notice (MCAN) or a TSCA Experimental Release Application 
(TERA).40 
There are legal questions about both the unintentional and intentional 
harms of synthetic biology. Unintentional harms include the possibility that 
artificial organisms could escape into the wild and cause environmental 
havoc.41 “Microorganisms adapt on their own terms, and the best scientists 
have little clue how to control this.”42 It is also well-documented that 
alteration of a single base pair within the billions found in the human genome 
is sufficient to cause disease when that change results in an amino acid 
 
35. Parent, supra note 17, at 320. 
36. Mandel & Marchant, supra note 9, at 155. 
37. Lynn L. Bergeson et al., Creative Adaptation: Enhancing Oversight of Synthetic Biology 
Under the Toxic Substances Control Act, 10 INDUS. BIOTECH. 313, 314 (2014). 
38. 15 U.S.C. § 2601 (2012); see also Benjamin D. Trump, Synthetic Biology Regulation and 
Governance: Lessons from TAPIC for the United States, European Union, and Singapore, 121 
HEALTH POL’Y 1139, 1141 (Table 1) (2017) (providing a summary of the regulatory coverage of 
synthetic biology). 
39. Bergeson et al., supra note 37, at 315.  
40. Microbial Products of Biotechnology, KELLER AND HECKMAN LLP (Jan 1, 2014), https://
www.khlaw.com/1194 [https://perma.cc/YH5R-3WTX]. For considerations regarding the TSCA’s 
applicability to living organisms, see Mandel & Marchant, supra note 9, at 175. 
41. “Regarding biosafety measures, a key ethical rationale is protection from harm. It is 
important to ensure the products of synthetic biology do not leave populations or environments 
worse off.” Ainsley J Newson, Synthetic Biology: Ethics, Exceptionalism and Expectations, 15 
MACQUARIE L.J. 45, 49 (2015). 
42. Parent, supra note 17, at 633; see also Newson, supra note 41, at 48. 
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substitution or a truncation error in an essential protein rendering it 
dysfunctional.43 
Intentional harms include the production of biological weapons, such as 
the malicious design of pathogens. “Th[is] worry has been sufficiently great 
that the synthetic biology community recently released a declaration publicly 
committing itself to improving the software that checks DNA synthesis 
orders for sequences encoding hazardous biological systems.”44  
Furthermore, where there are engineers, there are hackers.45 At the Synthetic 
Biology 2.0 meeting in 2006, a self-regulation attempt was therefore made to 
introduce a code of conduct to prevent the misuse of synthetic 
biotechnology.46    
NIH guidelines address research involving recombinant DNA.47 
Researchers at academic institutions may also receive some oversight 
through the NIH grant process and, before publication is allowed on human 
subjects, Institutional Review Board (IRB) review.48 However, industry and 
non-profit institutions are often self-funded and do not publish their research; 
therefore, they are not subject to the same restrictions. For example, the Gates 
 
43. Carles Ferrer-Costa et al., Characterization of disease-associated single amino acid 
polymorphisms in terms of sequence and structure properties, 315 J. MOLECULAR BIOLOGY 771, 
772 (2002).   
44. Sapna Kumar & Arti Rai, Synthetic Biology: The Intellectual Property Puzzle, 85 TEXAS L. 
REV. 1745, 1747 (2007). 
45. See Parent, supra note 17, at 317; see also Newson, supra note 41, at 48 (“Although 
researchers have established key components of biological knowledge, such as the sequence of the 
human genome, research to determine the function of genes and regulation of gene expression in 
complex organisms is less developed.”).  
46. Gardar Arnason, Synthetic Biology between Self-Regulation and Public Discourse: Ethical 
Issues and the Many Roles of the Ethicist, 26 CAMBRIDGE Q. OF HEALTHCARE ETHICS 246, 247–
48 (2017). 
47. NIH Guidelines, NAT’L INST. OF HEALTH: OFFICE OF SCI. POLICY (APRIL 2019), https://
osp.od.nih.gov/biotechnology/nih-guidelines/ [https://perma.cc/66N5-NF2M]. 
48. While both public and private—as well as non-profit and for-profit—organizations are all 
eligible to receive NIH grants, much funding goes to academic or NIH researchers. See Budget, 
NAT’L INST. OF HEALTH (last updated Jan. 24, 2019), https://www.nih.gov/about-nih/what-we-do
/budget [https://perma.cc/2VWM-D8MM]; see also BOS. PLANNING & DEV. AGENCY, BOSTON: 
MOST NIH FUNDS FOR 23 CONSECUTIVE YEARS 8 (2018), http://www.bostonplans.org
/getattachment/5cac1d8e-6fd7-4931-a029-6e5f39a28947 [https://perma.cc/5322-2XBD]; Grants & 
Funding, OFFICE OF EXTRAMURAL RESEARCH, NAT’L INST. OF HEALTH, https://grants.nih.gov
/grants/who-is-eligible.htm [https://perma.cc/7LJX-4QJN]; but see Gil Ben-Menachem et al., 
Doing business with the NIH, 24 NATURE BIOTECHNOLOGY 17, 17 (2006), https://
www.ncbi.nlm.nih.gov/pmc/articles/PMC2782946/ [https://perma.cc/9WLT-V85Q]. Yet, synthetic 
biological research occurs in university labs as much as for-profit commercial labs. Some science 
can even be done by individuals in their garages. Newson, supra note 41, at 49. For background on 
IRB review, see Lauren B. Solberg, Data Mining on Facebook: A Free Space for Researchers or 
an IRB Nightmare?, 2010 U. ILL. J.L. TECH. & POL’Y 311, 329–34 (2010). 
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Foundation funds various synthetic biology projects for commercial use,49 
and it was Oxitec’s technology in the Florida Keys that would have produced 
non-viable mosquito offspring in response to Zika.50  
There are additional complications to comprehensive regulation.51 
Synthetic biology research is conducted all across the globe. While there have 
been international efforts to address synthetic biology,52 governance systems 
are struggling to keep pace with the technological change. Once consensus 
occurs, the technology changes.53 
Some kind of comprehensive regulatory framework may eventually 
emerge, but not without difficulty.54 In the meantime, the result is a 
patchwork of laws. Yet, the implications of the technology are sweeping, 
raising ethical questions as well.   
IV.  The Ethics 
A legal framework in itself is insufficient to oversee synthetic biology. 
Laws are confined to jurisdictions, but synthetic biology developments occur 
all around the world. In addition, the law may have trouble keeping up with 
innovation.55 In such cases, ethical considerations may assist in guiding 
synthetic biology research.    
While similar to previous concerns with biotechnology,56 new ethical 
concerns have been raised. Loike and Pollack have recently called for an 
Asilomar-style conference to evaluate future risks of synthetic biology. 57 “In 
so far as there are novel ethical issues arising from synthetic biology, they 
concern the relationship we humans have to nature or life when we can 
 
49. Jenny Rooke, Synthetic biology as a source of global health innovation, 7 SYS. & 
SYNTHETIC BIOLOGY 67, 68 (2013). 
50. See supra note 1 and accompanying text. 
51. There are other legal implications, including intellectual property. See, e.g., Andrew W. 
Torrance, Synthesizing Law for Synthetic Biology, 11 MINN. J.L. SCI. & TECH. 629, 633 (2010).   
52. See, e.g., Karolyn White & Subramanyam Vemulpad, Synthetic Biology and the 
Responsible Conduct of Research, 15 MACQUARIE L.J. 59, 59–60 (2015) (noting international 
responses). 
53. See, e.g., Ayelet Blecher-Prigat, Rethinking Visitation: From a Parental to a Relational 
Right, 16 DUKE J. GENDER L. & POL’Y 1, 11 (2009) (“Thus far, current law has failed to keep up 
with changing social norms and bio-technological changes[.]”). 
54. Parent, supra note 17, at 338. In the U.S. context, what legislation will be required, and how 
will it get through Congress? The research itself might be a target for regulation, as well as the 
resulting products. See Newson, supra note 41, at 53 (“Three approaches to governance are 
anticipatory governance, adaptive governance and responsible research and innovation (RRI).”). 
55. See id. 
56. See e.g., Newson, supra note 41, at 55 (“It seems clear that synthetic biology does not 
present any completely new ethical issues, and that ethical analysis within synthetic biology 
should not be described as a discrete field of inquiry within bioethics.”).  
57. See Loike & Pollack, supra note 24. 
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rationally design and engineer living systems free of the constraints of 
evolution.”58 
Many of the ethical questions raised by synthetic biology relate to 
questions about life. Should scientists create new life forms that do not 
already exist by synthetically creating DNA sequences, thereby 
circumventing the natural process of evolution? Furthermore, what about 
mistakes in creating life that affect the organism negatively? Should life be 
specifically created for unpleasant roles, such as yeast for gulping up oil? 
Thomas Hobbes predicted that life outside society would be “solitary, poor, 
nasty, brutish, and short,”59 and perhaps that is where some synthetically 
created life would fall. This raises concerns regarding the treatment of life 
created by synthetic biology, which requires determining “at what point a 
new life form created by synthetic biology attains moral status.”60  
Yet, synthetic biology challenges the very definition of life. Previously, 
genes needed to be inherited. Now, they can be created in a laboratory and 
linked to make an entirely new life form. Defining “life” is already difficult 
without synthetic biology to push the boundaries, and even in simpler 
contexts, no consensus has developed.61 Requirements for a genetic 
information system that could sustain life include nucleobase building blocks 
that are chemically stable, thermodynamically stable, replicable by enzymes 
such as polymerases, and kinetically selectable.62 Life is not just an organism 
containing DNA, however. Origin-of-life scientists would insist that life, by 
definition, requires the ability to evolve.63      
Furthermore, does it matter if the life began in a laboratory? Is it life if 
it could have never existed naturally or if it was built from a synthetic 
genome? At least to these questions, a consensus is emerging that “we should 
 
58. Arnason, supra note 46, at 247. 
59. THOMAS HOBBES, LEVIATHAN: OR THE MATTER, FORME, AND POWER OF A COMMON-
WEALTH, ECCLESIASTICALL AND CIVILL 77–78 (1651). 
60. Newson, supra note 41, at 48. 
61. Much literature concludes that “a single definition [of life] is not possible nor would such a 
definition be stable.”  Id. at 47. “The pre-theoretic notions of the concept of ‘life’ do not match up 
with the diversity of beings we see in nature. A common response has been to continue this debate 
in hope of coming to a consensus with respect to these counterexamples. Others . . . are pessimistic 
about current approaches and seek new evidence. Their ‘wait-and-see’ approach is gaining in 
popularity.” Carlos Mariscal & W. Doolittle, Life and Life Only: A Radical Alternative to Life 
Definitionism, SYNTHESE 1, 4 (2018) (citations omitted), https://doi.org/10.1007/s11229-018-1852-
2 [https://perma.cc/WZA4-YXUQ]. 
62. Eörs Szathmàry, Why Are There Four Letters in the Genetic Alphabet?, 4 NATURE REVIEWS 
GENETICS 995, 995 (2003). 
63. See, e.g., William A. Dembski & Jonathan Wells, Must Life Evolve? EVOLUTION NEWS 
(July 27, 2017), https://evolutionnews.org/2017/07/must-life-evolve/ [https://perma.cc/SF56-
AQN2]. 
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look at the properties of an entity to determine its moral status, not how that 
entity was made.”64  
Regardless of the definition of life, synthetic biology is the tool to build 
life as we want it to be, but how far should it go? Creating yeast that emits 
perfume is one thing, but what about building other creatures? Synthetic 
biology can bring back extinct creatures and prevent future extinction by 
constructing entire creatures with artificial genomes. It can also create a 
synthetic human by building all of its genome in the lab—early plans, now 
scaled back, included synthesizing the entire human genome.65 There is, 
however, an incentive of synthetic biology to be limited to simple biological 
structures because those can be better programmed.66    
Some implications of the technology are more palatable than others—
palatable enough to make the whole field of synthetic biology so. For 
example, a synthetic biology product that people swallow can replace the 
current unpleasant colonoscopy test.67 Whereas the legal regulation of 
synthetic biology has taken a piecemeal approach, much of the ethics work 
has evaluated synthetic biology as a whole, but are the field and its 
consequences clear yet?  
As the technology evolves, what about the ethical aspects related to 
benefit sharing, such as whether patenting an artificially synthesized genome 
is appropriate?68 Ethical considerations could affect pricing and accessibility 
to the resulting products. Institutions have approached this differently. The J. 
Craig Venter Institute patented the sequence of the minimal genome in 2007, 
in contrast to the BioBricks Foundation, which has adopted an open-source 
model.69 
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 Finally, what are the ethics of not using synthetic biology? Whether it is 
food, fibers, perfumes, or plastics, many products made today require 
immense resources to extract their basic materials. This may become 
problematic as the population continues to grow around the world, increasing 
the demand for these products to unsustainable levels.70 Synthetic biology 
offers a new way to fabricate the same goods with far fewer resources. Cell-
produced products could replace many industrial and chemical processes in 
food, fuel, medicine, proteins, and materials, except with far fewer inputs and 
negative side effects. Hundreds of versions of microbes can be tested to find 
the ones that maximize production.71 Synthetic biology may become less 
elective as the world’s resources become more strained.  
V. Conclusion 
Although the current legal framework treats synthetic biology as the 
continuation of the status quo, synthetic biology allows scientists to do more 
than ever before. Considering the short history of synthetic biology, however, 
the future is unknown. Now is the time to explore the relevant legal and 
ethical questions, with some of them having spilled over from biotechnology 
and similar fields.  
Innovation is essential.72 While Frankenstein is a mythical result of 
synthetic biology technology, an example of what has yet to be created, and 
the symbol of doom and gloom resulting from human tinkering with biology, 
a host of solutions to humanity’s greatest problems—human health, welfare, 
and environment—is also possible.  
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